CervoMed Inc. (CRVO) - Latest Market Data

Price & Market Data

Price: $3.20

Daily Change: +$0.108 / 3.38%

Daily Range: $3.06 - $3.22

Market Cap: $28,331,680

Daily Volume: 102,002

Performance Metrics

1 Week: -15.62%

1 Month: -21.10%

3 Months: -37.51%

6 Months: -65.09%

1 Year: -63.30%

YTD: -60.55%

About CervoMed Inc. (CRVO)

Get current market data for CervoMed Inc. (CRVO). Price: 3.20, daily change: +$0.108 / 3.38%. Market cap: 28,331,680. Performance YTD, 1-week, 3-month.

Company Details

Employees: 15

Sector: Commercial services

Industry: Miscellaneous commercial services

Country: United States

Details

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Selected stocks

Myseum.AI, Inc. (MYSE)

SemiLEDS Corporation (LEDS)

Sera Prognostics, Inc. (SERA)

Dare Bioscience, Inc. (DARE)

Springview Holdings Ltd (SPHL)